TradingView
Kareim
14 Şub 2018 22:32

New Support Being Created 

Açıklama

Despite failure at drug trials, stock still ranked "strong buy" by TipRank's 60th best rated analyst and others. May be a an opportunity to buy Call LEAP
Daha Fazla